Letter to our Stockholders

Close this search box.

Science Spotlight

Raising the Voice: A Comment on Race and Ethnic Disparities in Alzheimer’s Disease Clinical Research

Alzheimer’s Disease clinical research has faced a significant challenge for a long time in achieving diverse racial or ethnic representation in clinical trials. Many of these issues are rooted in deeper structural problems that leave some populations apart from the scope of science. While much work remains to be done to address this subject, there is a growing demand for more representative clinical trial data.

Read More »

Hypertension as a Risk Factor for Cognitive Decline

Hypertension, or high blood pressure, significantly impacts public health worldwide. Hypertension is well recognized for its role in cardiovascular disease, revealing implications for cognitive decline and dementia. Increasing clinical evidence for the early detection, management, and prevention of this condition may provide insights into a more comprehensive patient care, a more effective prevention of cognitive decline, and an improvement of overall quality of life.

Read More »

Psychosis in Parkinson

Parkinson’s awareness month
Parkinson’s disease psychosis is a neuropsychiatric complication that affects more than 20% of patients affected by Parkinson’s. Common symptoms involve visual or auditory hallucinations, distorted perception, and experiences. More challenging symptoms may occur in the form of delusions, which
often cause agitation, aggressiveness, and affect the quality of life of the patient and their families.

Read More »

The Synesthetic Brain

Synesthesia is a complex experience that involves perceiving the elements of the world with more than one sense. By integrating the knowledge of neuroscience with these aspects of perception, scientists have been able to map synchronous patterns of activation in brain regions that do not entirely relate to the stimulus nature. The intriguing nature of this process invites people to be more aware of what they can perceive in a world saturated with external information.

Read More »
artificial intelligence

Artificial Intelligence and Alzheimer’s Disease

In Alzheimer’s disease research, the integration of artificial intelligence (AI) enables researchers to uncover patterns and biomarkers faster, facilitating earlier diagnosis and personalized therapies. Embracing these new technologies not only enhances the understanding of AD but also propels the development of innovative treatments for this complex neurological condition.

Read More »

Musical Memories and Alzheimer’s Disease

Music therapy can improve the quality of life for patients with Alzheimer’s disease by reducing agitation and depression while also improving mood and social interaction. Music serves as a powerful tool for improving communication and emotional well-being. It is particularly effective in facilitating a connection with their past and sense of identity.

Read More »